Nykode Therapeutics A Eulerpool naujienos

Nykode Therapeutics A Eulerpool News

Nykode Therapeutics A akcijų naujienos

Nykode Therapeutics A stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Nykode Therapeutics A naujienas mes pateikiame čia.

• rugpjūčio 14 d. ·

  Yahoo
  Nykode Therapeutics Announces Issuance of Key Patent Covering Individualized Neoantigen Based Vaccines
• birželio 20 d. ·

  Yahoo
  Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting
• birželio 11 d. ·

  Yahoo
  Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy
• gegužės 14 d. ·

  Yahoo
  Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HPV16-Positive High-Risk Locally Advanced Cervical Cancer
• gegužės 14 d. ·

  Yahoo
  Nykode Therapeutics - Quarterly report Q1 2024
• balandžio 19 d. ·

  Yahoo
  Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
• kovo 21 d. ·

  Yahoo
  Nykode Therapeutics Announces Topline Conclusions Affirming Prolonged Clinical Benefits from Matured Survival Data in Phase 2 C-02 Trial in Advanced Cervical Cancer
• kovo 19 d. ·

  Yahoo
  Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases
• lapkričio 15 d. ·

  Yahoo
  Nykode Therapeutics - Quarterly report Q3 2023
• spalio 9 d. ·

  Yahoo
  Nykode Therapeutics to Present at the mRNA Cancer Vaccines Summit 2023 in Boston